Labcorp Holdings Files 8-K
Ticker: LH · Form: 8-K · Filed: Jan 8, 2025 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Jan 8, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, disclosure
Related Tickers: LH
TL;DR
Labcorp filed an 8-K, likely with financial updates. Watch for details.
AI Summary
On January 8, 2025, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the filing of Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates that Labcorp Holdings is providing updates or disclosures to the SEC, which could contain important information for investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific material events or financial data that would indicate a high risk.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Registrant
- 0000920148-25-000006 (filing_id) — Accession Number
- January 8, 2025 (date) — Filing Date
- 358 South Main Street, Burlington, North Carolina 27215 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for LABCORP HOLDINGS INC.?
The filing is primarily for Regulation FD Disclosure and the filing of Financial Statements and Exhibits.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is LABCORP HOLDINGS INC.
On what date was this 8-K filing made?
The filing was made on January 8, 2025.
What is the address of LABCORP HOLDINGS INC.'s principal executive offices?
The address is 358 South Main Street, Burlington, North Carolina 27215.
What is the Commission File Number for LABCORP HOLDINGS INC.?
The Commission File Number is 1-11353.
Filing Stats: 438 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2025-01-08 16:32:15
Key Financial Figures
- $0.10 — ange on which registered Common Stock, $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20250108.htm (8-K) — 25KB
- formpr4q24ex991earningsann.htm (EX-99.1) — 6KB
- lc2020logov2a.gif (GRAPHIC) — 5KB
- 0000920148-25-000006.txt ( ) — 161KB
- lh-20250108.xsd (EX-101.SCH) — 2KB
- lh-20250108_lab.xml (EX-101.LAB) — 22KB
- lh-20250108_pre.xml (EX-101.PRE) — 12KB
- lh-20250108_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2024 before the market opens on Thursday, February 6, 2025, and will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press release dated January 8, 2025 issued by Labcorp Holdings Inc.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant Date: January 8, 2025 By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary